Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - OTHER CURRENT LIABILITIES
Other Current Liabilities NVAX - Novavax, Inc.
1.26 B
LAST VALUE
33.03%
2 YEAR CAGR
116.80%
5 YEAR CAGR
59.63%
10 YEAR CAGR